Michael Kleinemeier Chairman of the Merck Supervisory Board until the 2024 AGM

09-Feb-2024 - Merck announced that the Supervisory Board has elected Michael Kleinemeier (66) as its Chair. Among other roles, Kleinemeier was a member of the Executive Board of SAP SE, Walldorf, as Head of SAP Digital Business Services from 2015 to 2020. He has been a member of the Merck Supervisory Board ...

Minimise errors in pharmaceutical processes and reduce risks

Tyrolean start-up Innerspace secures € 5.7 Million for Further Expansion to the USA

06-Feb-2024 - The Innsbruck-based tech start-up Innerspace, which enables risk assessment of production processes and effective training of cleanroom personnel for leading pharmaceutical companies using software and Virtual Reality (VR), can advance its growth trajectory after a highly successful funding ...

Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases

Calluna Pharma has a pipeline of selective antibodies targeting immunological diseases

01-Feb-2024 - Oxitope Pharma (Oxitope) and Arxx Therapeutics (Arxx), companies with a shared goal of leveraging the innate immune system to discover and develop disease modulating therapies, announced their merger to form Calluna Pharma Inc. (Calluna). Calluna has raised EUR 75 million in a series A financing ...

Puffed-up MOFs for improved drug delivery

31-Jan-2024 - The spongelike structure of metal organic frameworks (MOFs) allows these polymers to possibly carry and deliver a range of therapeutic compounds. Now, researchers reporting in ACS Applied Bio Materials treated a chromium-containing MOF with a dose of acetic acid, more concentrated than in ...

Start-up Dynamic42 and Biopredic join for strategic Marketing agreement

New partnership to promote pioneering in vitro systems in drug development

30-Jan-2024 - The organ-on-chip specialist Dynamic42 GmbH and Biopredic, manufacturer of assay systems for research, announce a strategic Marketing agreement. The joint partnership aims to advance the development of in vitro assay systems by using human-relevant models in the early phase of drug ...

Jean-Marc Huët to succeed Albert M. Baehny as Chairman of Lonza

Longstanding Chairman of Lonza, Albert Baehny will not stand for re-election

29-Jan-2024 - After seven years as Board member and six years as Chairman of Lonza, Albert Baehny has decided to not stand for re-election at the upcoming Annual General Meeting (AGM) in May 2024. The Board of Directors recognizes the instrumental role of Albert Baehny during his tenure, including leading the ...

Revvity Elects Sophie Vandebroek and Michael Klobuchar to its Board of Directors

Sylvie Gregoire leaves Revvity Board of Directors

26-Jan-2024 - Revvity, Inc. announced that Sophie Vandebroek and Michael Klobuchar have been elected to its board of directors, effective February 1, 2024. “I am pleased to welcome Michael Klobuchar and Sophie Vandebroek to Revvity’s board and look forward to their contributions as we execute on our strategic ...

Kizoo leads financing round in Reservoir Neuroscience to restore health to the aging brain

A first-in-kind compound reverses disease in blood vessels and repairs the damaged blood-brain barrier

24-Jan-2024 - Reservoir Neuroscience announced the completion of a $4M financing round to support the development of new therapies for age-related neurodegeneration. Reservoir will use the funds to develop its novel class of drug compounds designed to restore health to the brain’s blood vessels to rejuvenate ...

A navigation system to combat bottlenecks in medication supply

Tool for supervisory authorities

22-Jan-2024 - A new model designed by ETH Zurich researchers measures how flexible medication distribution systems are in real time. It shows that supply shortages can be eased if pharmaceutical wholesalers coordinate their inventories and reroute scarce products as flexibly as possible along existing supply ...

Bayer aims to sustainably improve performance with new organization

New operating model aims to reduce hierarchies, eliminate bureaucracy and accelerate decision-making processes

18-Jan-2024 - The Bayer Group is introducing a new operating model called “Dynamic Shared Ownership” (DSO) worldwide, which will reduce hierarchies, eliminate bureaucracy, streamline structures and accelerate decision-making processes. The aim of the new operating model is to make the company much more agile ...